It would be reasonable to assum e that as th e m ean age of th e U nited States population rises , th e inciden ce of como rbid m edi cal a nd psychi a tric d isease is incr easing. Patients a re oft en pr escribed m edi cations whi ch m ay int e ract with psychotropic drugs . Second-generation ant idepressants a re ge ne ra lly co ns id e red safe drugs in th e m edi call y ill popu lation beca use of t heir minim al a n t icho line rg ic properti es and fewer adve rse sid e effec ts. Fo r th e ph ysician , a kn owled ge of drug int eractions with th e most co m mo nly prescribed psychotropic m edi catio ns is no t only helpful, but should be th e standard of ca re.
Rece n tly, we were asked to see a woman with recurrent d epression a nd a history of deep ve in thrombosis. Sh e had been initially s tar te d o n Pro zac (fluo xe t ine ) an d was se condarily started on Co umad in (warfarin) . The pat ient pr esent ed with seve re bru ising of bot h lowe r ex t re mi t ies a nd a seco ndary cellu litis . An added co m plica ting fact was that she had a Di pthe ria , Pertussis, T et anus vaccination 3 week s prior to ad m issio n. Bot h ce llulitis and th e D .P.T. va ccin at ion pot entiall y int e rfe re with coag ula t io n. On admission her Pro t h ro m bin Tim e (PT) was 50 a nd Part ial Th romb oplastin Tim e (PTT) was 100, a sce nario more co ns iste nt with a coagulopa thy rath er than Coumadin toxicity.
Whe n as ked to consu lt on this case , we had to investigat e th e possibil ity of P ro zac int e ract ing wit h Coumadin. The Ph ysicia ns Desk Refere nce ca u tions agains t coa d m iniste ring th e two drugs . (I) Co u madin, a co m mo nly pr escribed a nt icoagula n t, is bound to th e sam e plasma pr ot ei n which binds Prozac. It is possibl e th at Pr ozac m ay di splace Coumadin from its binding prot e in a nd result in a n incr ease in a fr ee fract ion of Coumadin , ca using a n incr ease in Protim e ( 1,3,). A se a rc h of th e m edi cal lit era ture fai ls to de monst ra te a ny cases of Pro zac int eracting with C oumadin (2). In our case, a d efini te ca use a nd effec t linka ge co uld not be es tablishe d.
It was th en elec te d to perform a ret rosp ecti ve char t revi ew of patients who were coa d mi niste re d Pro zac a nd Coumad in . T o dat e, we have rev iewed an addition al 4 ca ses .
Patient A is a 75 year old whit e mal e with a hist ory of chro nic ob structiv e pulmon a ry disease, co ro na ry a r tery di sease, multiple myoca rdi a l infarct s, a t ria l fibrilla t ion, a nd recurrent t ransient isch e mic a t tacks. Th e patie n t was found to ha ve m aj or d epression a nd mild dem entia. H e had been on lon g term Coumadin th er ap y pri or to th e initiation of Prozac. At this juncture, Pr ozac a nd Co umadi n have j ointly been administered for I yea r. Th e patient maint a in ed his PT ra tio between 1.3 a nd 1.5 of PT co n t ro l range wit ho u t need to adj us t th e dosa ge.
Patient B, a 67 year old m al e, has a history of mu ltiple ce re bra l vasc ular acc ide n ts. H e pres ent ed to Ment al H ygi en e C linic wit h major depressi on . T o dat e, he has been m aint ained on Pr oza c a nd Co u mad in for eig ht week s. Hi s PT has rema ined within sa t isfac tory cuntrollimits without having to be adju st ed .
Pati ent C, a 73 year old m al e, is sta t us post coro na ry a rt e ry bypass graft , a nd II periph eral vascula r by-pass g ra fts . H e has a hist ory of deep vein t hrombophl ebit is a nd has been m a intain ed on C ou mad in th erap y for 12 years . H e was sta r t ed on Prozac for depression 2 years ago. T o dat e he ha s required no special ad justm ent to st ay within con t rol range.
Pati ent D is a 67 year old mal e with a histo ry of dee p vei n t hrombophleb iti s, pulmon a ry e m bo li a nd sq uamo us ce ll ca rcinom a of t he tongue. H e has undergon e radi cal neck di ssecti on a nd ex te rnal beam radi ation t herapy. The patient has been on C oum adin for 12 years. Hi s psychi atric hist or y is remarkabl e for schizophreni a a nd int ermitt ent depression . H e wa s placed on Pr ozac 3 months ago, wh en he experie nce d o rt hos tat ic blood pressure cha nges fr om his t ricyclic a ntidepressants. In th e int ervening period , he has required no specia l dosa ge adjustm ent to stay within param et ers.
Our purpose in writing thi s report is to inform o t he r cli nicians t ha t although in theory Coumadin a nd Prozac may int eract a nd a lte r Prothrombin Tim e, th e po tential a t this tim e a ppe a rs small. Both Cou mad in an d Pr ozac ca n eas ily be displaced by o t her highl y pr ot ein bound drugs. Proza c does not a ppea r to alter the outcom e of a n ticoag ula n t th erapy sig nifica n t ly in th e pa t ie n ts p resen te d.
No cases of C oumadin int eracting with Pro zac have a ppeared in th e world 's lit erature (2) . Our inv estigation involves 5 patients a nd ca nno t be conside red definitive. It would be prudent to st udy a larger population before th e safet y of it s com bina tio n with C oumadin ca n be det e rmined .
Eli Lilly a nd Compan y, th e manufacturers of Pr ozac, re por t that as ofJune 30, 1990, a pp roximate ly 2,382,000 pa ti ents have bee n on Prozac. T here have be en only 24 rep ort ed cases of incr ease in bleeding tim e, coagulation d iso rd er , or coa gu la t ion tim e increase. W e do not kn ow wh e th e r a ny of th ese pa t ien ts were concurrently on Pr ozac and Coumadin . It is our hop e th a t t his art icle challenges ot he r investigat or s.
